Historical Stock Price
ABEO historical stock prices picture
Abeona Therapeutics (ABEO) has the following price history information. Looking back at ABEO historical stock prices for the last five trading days, on November 29, 2021, ABEO opened at $0.82, traded as high as $0.83 and as low as $0.64, and closed at $0.65. Trading volume was a total of 3.09M shares. On November 30, 2021, ABEO opened at $0.66, traded as high as $0.69 and as low as $0.65, and closed at $0.69. Trading volume was a total of 1.09M shares. On December 01, 2021, ABEO opened at $0.69, traded as high as $0.70 and as low as $0.60, and closed at $0.60. Trading volume was a total of 1.14M shares. On December 02, 2021, ABEO opened at $0.63, traded as high as $0.65 and as low as $0.60, and closed at $0.61. Trading volume was a total of 997.70K shares. On December 03, 2021, ABEO opened at $0.61, traded as high as $0.61 and as low as $0.56, and closed at $0.57. Trading volume was a total of 910.10K shares.

ABEO Historical Stock Prices By Date:

ABEO historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Abeona Therapeutics shares, starting with a $10,000 purchase of ABEO, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 12/06/2011
End date: 12/03/2021
Start price/share: $1.43
End price/share: $0.57
Dividends collected/share: $0.00
Total return: -60.14%
Average Annual Total Return: -8.79%
Starting investment: $10,000.00
Ending investment: $3,984.97
Years: 10.00
Date Open High Low Close Volume
11/29/2021 $0.82 $0.83 $0.64 $0.65 3.09M
11/30/2021 $0.66 $0.69 $0.65 $0.69 1.09M
12/01/2021 $0.69 $0.70 $0.60 $0.60 1.14M
12/02/2021 $0.63 $0.65 $0.60 $0.61 997.70K
12/03/2021 $0.61 $0.61 $0.56 $0.57 910.10K
Abeona Therapeutics is a biopharmaceutical company developing gene and cell therapies for rare genetic diseases. Co.'s clinical programs consist of: EB-101, an autologous, gene-corrected cell therapy for recessive dystrophic epidermolysis bullosa; ABO-102, an adeno-associated virus (AAV)-based gene therapy for Sanfilippo syndrome type A; and ABO-101, an AAV-based gene therapy for Sanfilippo syndrome type B. Co. has other AAV-based gene therapies in developmental stages designed to treat the CLN1 and CLN3 forms of Batten Disease, cystic fibrosis and retinal diseases. Co. is also developing AAV-based gene therapies through its AIM™ capsid platform and internal AAV vector research programs.
Date Close
11/29/2021$0.65
11/30/2021$0.69
12/01/2021$0.60
12/02/2021$0.61
12/03/2021$0.57
ABEO is categorized under the Healthcare sector; below are some other companies in the same sector:

ABIO Historical Stock Prices
ABMD Historical Stock Prices
ABT Historical Stock Prices
ABV Historical Stock Prices
ACAD Historical Stock Prices
ACER Historical Stock Prices
ACET Historical Stock Prices
ACHC Historical Stock Prices
ACHN Historical Stock Prices
ACHV Historical Stock Prices

Also explore: ABEO shares outstanding history

Email EnvelopeFree ABEO Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts


ABEO Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2021, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.